Development and Characterization of a Next Generation Genome Engineering Tool for Gene Therapy
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This thesis presents a comprehensive study on engineering, evaluating, and advancing the functionality of the Sleeping Beauty (SB) transposon system for applications in genome engineering. The overarching goal was to enhance the control, activity, and precision of SB-mediated gene transfer in human cells, which is essential for safe and effective therapeutic interventions. To this end, the project was divided into four major parts. First, a large-scale mutational screening strategy was developed to identify novel hyperactive SB transposase variants. A retroviral delivery system was used to introduce libraries of SB transposase mutants into human reporter cell lines, followed by antibiotic-based selection to enrich for more active variants. Nanopore sequencing enabled the identification of enriched mutations within the SB coding sequence. This approach not only yielded functionally relevant candidate mutations but also established a high-throughput platform to connect phenotype with genotype, enabling future functional genomics and enzyme evolution studies. In the second part, a novel split-intein-based system was engineered to enable spatiotemporal control of SB transposase activity. The SB transposase was systematically split at permissive positions and reconstituted via intein-mediated protein splicing. Using doxycycline-inducible and tissue-specific promoters, transposase activity could be restricted to specific time points or cell types. This system was validated in co-culture assays with HEK293T and HepG2 cells, demonstrating functional integration only in the targeted population. Furthermore, the split system was adapted to enable targeted integration by fusing the DNA-binding-deficient SB N-terminal domain to dCas9, which should guide integration toward defined genomic loci. These data underscore the potential of the split SB system as a programmable and safer alternative to constitutively active gene delivery vectors. The third focus of this thesis was on characterizing the novel Q124C variant, a hyperactive SB transposase discovered during the intein splicing experiments. This variant demonstrated increased transposition activity compared to SB100X and showed resistance to overproduction inhibition, making it a promising tool for gene therapy. Biochemical and structural insights into the mutation's location provided clues into its enhanced activity, highlighting the role of specific residues in modulating enzyme performance. The fourth part addressed the phenomenon of “local hopping,” the tendency of SB to reintegrate near its original genomic site. To dissect the mechanistic basis of this behavior, different SB transposase variants were tested in a remobilization assay using a single-copy reporter cell line. It was found that dimer-stabilizing constructs or charge-modified transposases, such as SBc42, influenced chromatin binding but not necessarily local hopping frequency. These findings emphasize the complex interplay between transposase structure, chromatin context, and integration behavior, pointing toward nuclear architecture as a critical parameter in transposon-based genome engineering. Collectively, this work expands the functional landscape of the SB transposon system. It provides new tools and methodologies for precise, efficient, and controllable genome modification and paves the way for future therapeutic strategies that require both high performance and safety.
Fields of Study & Subjects
Virus-based gene therapy research
CRISPR and Genetic Engineering
RNA Interference and Gene Delivery
Publication details
- Journal / source
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Thesis